Research Progress of Diagnosis and Treatment of Glioblastoma
10.3971/j.issn.1000-8578.2022.22.0090
- VernacularTitle:胶质母细胞瘤诊疗研究进展
- Author:
Qianxue CHEN
1
Author Information
1. Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
- Publication Type:Research Article
- Keywords:
Glioblastoma;
Molecular pathology;
Targeted therapy;
Immunotherapy;
Tumor treating fields
- From:
Cancer Research on Prevention and Treatment
2022;49(11):1103-1106
- CountryChina
- Language:Chinese
-
Abstract:
Glioblastoma is the most common primary malignant brain tumor. Despite large-scale researches have been carried out, the prognosis of glioblastoma is still not significantly improved. In recent years, with the application of multi-omics studies in glioblastoma, the understanding of glioblastoma has been deepened. The classification of glioblastoma has been revised; moreover, new therapeutic methods such as targeted therapy, immunotherapy and tumor treating fields have been developed on the basis of the standard therapy. This article reviews the recent progress in the diagnosis and treatment of glioblastoma.
